share_log

CureVac Has Started The Phase 1 Part Of A Combined Phase 1/2 Study Of An Investigational Influenza A (H5N1) Pre-Pandemic Vaccine Candidate Developed In Collaboration With GSK, H5N1 Is An Avian Influenza Virus

CureVac Has Started The Phase 1 Part Of A Combined Phase 1/2 Study Of An Investigational Influenza A (H5N1) Pre-Pandemic Vaccine Candidate Developed In Collaboration With GSK, H5N1 Is An Avian Influenza Virus

CureVac已經開始了與葛蘭素史克合作開發的正在研究的甲型流感（H5N1）大流行前候選疫苗的1/2期聯合研究的第一階段部分，H5N1是一種禽流感病毒
Benzinga ·  04/24 19:20

CureVac Has Started The Phase 1 Part Of A Combined Phase 1/2 Study Of An Investigational Influenza A (H5N1) Pre-Pandemic Vaccine Candidate Developed In Collaboration With GSK, H5N1 Is An Avian Influenza Virus

CureVac已經開始了與葛蘭素史克合作開發的正在研究的甲型流感（H5N1）大流行前候選疫苗的1/2期聯合研究的第一階段部分，H5N1是一種禽流感病毒

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論